ERBB2 and neoplasm: As mentioned earlier, mathematical models that depict the pharmacokinetics and pharmacodynamics of these potential drugs, their combinations, and their effect on individual cell dynamics in the heterogeneous tumor microenvironment can accelerate the search for better treatment options for HER2+ BC (See Figure 1).